Safety of in utero exposure to maternal IBD pharmacotherapies

Nat Rev Gastroenterol Hepatol. 2022 Apr;19(4):213-214. doi: 10.1038/s41575-021-00572-9.

Ralley E Prentice^{1

2

3

4}, Sally J Bell^{1

2}, Claudia A Nold-Petry^{4

5}, Marcel F Nold^{4

5

6}, Rimma Goldberg^{7

8

9}

¹ Gastroenterology Department, Monash Health, Melbourne, Victoria, Australia.
² School of Clinical Sciences, Department of Medicine, Monash University, Melbourne, Victoria, Australia.
³ St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
⁴ Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Victoria, Australia.
⁵ Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.
⁶ Monash Newborn, Monash Children's Hospital, Melbourne, Victoria, Australia.
⁷ Gastroenterology Department, Monash Health, Melbourne, Victoria, Australia. rimma.goldberg@monash.edu.
⁸ School of Clinical Sciences, Department of Medicine, Monash University, Melbourne, Victoria, Australia. rimma.goldberg@monash.edu.
⁹ Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Victoria, Australia. rimma.goldberg@monash.edu.

No abstract available

Publication types